Sarcoma
IRB #H-32125/ALLIANCE A091102: Phase II Study of MLN8237 in Advanced/Metastatic Sarcoma
*cohort 1 (liposarcoma) accrual suspended 1/17/13*
*cohort 2 (leiomyosarcoma (non-uterine)) accrual suspended 3/22/13 *
*cohort 3 (undifferentiated sarcoma) accrual suspended 3/20/13 *
*cohort 4 (malignant peripheral nerve sheath tumor)accrual to be suspended 5/20/13*
*cohort 5 (other sarcomas) accrual suspended 03/12/2013 *
